Alternatives to in vivo nasal toxicological screening for nasally-administered drugs

S.T.P. Pharma Sciences

Volumn 12, Issue 1, 2002, Pages 13-22

  Agu, R U ^a   Jorissen, M ^a   Kinget, R ^a   Verbeke, N ^a   Augustijns, P ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Cilio toxicity; In situ perfusion; In vitro models; Nasal drug delivery; Nasal drug toxicity

Indexed keywords

DRUG ABSORPTION; DRUG COST; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG INDUSTRY; DRUG METABOLISM; DRUG SCREENING; DRUG SYNTHESIS; INTERMETHOD COMPARISON; MUCOCILIARY CLEARANCE; NOSE MUCOSA; PHARMACY; REVIEW; TOXICOLOGY;

EID: 0036148635     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. The nasal delivery of drugs
2. Chemical stability, enzymatic hydrolysis, and nasal uptake of amino acid ester prodrugs of acyclovir
3. New approach for oral administration of insulin with polyalkylcyanoacrylat nanocapsules as drug carrier
4. Preliminary study of oral polylactide microencapsulated insulin in vitro and in vivo
5. Delivery of peptide and non-peptide drugs through the respiratory tract
6. Transmucosal delivery systems for calcitonin: A review
7. Effects of proteolytic enzyme inhibitors on the nasal absorption of vasopressin and an analogue
8. Evaluation of enhancers to increase nasal absorption using Ussing chamber technique
9. Enhanced nasal delivery of luteinizing hormone releasing hormone agonist buserelin by oleic acid solubilized and stabilized in hydroxypropyl-betacyclodextrin
10. Screening of cationic compounds as an absorption enhancer for nasal drug delivery
11. Effects of pharmaceutical compounds on ciliary beating in human nasal epithelial cells: A comparative study of cell culture models
12. Toxicity tests in animals: Alternative models
13. In vitro tests for respiratory toxicity
14. Metal toxicity and the respiratory tract
15. Intrapulmonary antigen deposition in the human lung: Local responses
16. Immunological functions of the pulmonary epithelium
17. Tolerance investigation of medical products for nasal use in buccal and nasal administration as an alternative to parenteral administration
18. Secretion, pain and sneezing induced by the application of capsaicin to the nasal mucosa in man
19. Distinctive patterns of release of neuroendocrine peptides after nasal challenge of allergic subjects with rye grass antigen
20. Mucociliary clearance in the airways
21. An in vitro model for measuring tryptase release from nasal mucosa in response to allergen challenge
22. Metabolism-dependent activation and toxicity of chemicals in nasal glands
23. Drug metabolism in the nasal mucosa
24. Metabolism of progesterone by the nasal mucosa in mice and rats
25. Biochemical quantitation and histochemical localization of carboxylesterase in the nasal passages of the Fischer-344 rat and B6C3F1 mouse
26. Intranasal drug delivery
27. Effects of the respiratory tract on inhaled materials
28. In vitro cell models to study nasal mucosal permeability and metabolism
29. The assessments of tobacco smoke toxicity of fetal rabbittracheal epithelium to shortterm exposures of whole smoke
30. Use of tracheal organ cultures in toxicity testing
31. Tracheal epithelium in culture: A model for toxicity testing of inhaled molecules
32. Effect of mineral particles containing iron on primary cultures of rabbit tracheal epithelial cells: Possible implication of oxidative stress
33. In vitro nasal drug delivery studies: Comparison of derivatized, fibrillar and polymerized collagen matrix-based human nasal primary culture system for nasal drug delivery studies
34. Safety and efficacy of protease inhibitors as nasal absorption enhancer for leucine encephalin: An in vitro study using human nasal cell monolayers
35. Effects of bile salts on nasal permeability in vitro
36. Absorption of recombinant methionyl-human growth hormone (Met-hGH) from rat nasal mucosa
37. Nasal drug delivery: An in vitro characterization of transepithelial electrical properties and fluxes in the presence or absence of enhancers
38. The effect of permeation enhancers on the surface morphology of the rat nasal mucosa: A scanning electron microscopy study
39. Nasal absorption in rats. II. Effect of enhancers on insulin absorption and nasal histology
40. Cyclodextrins as protection agents against enhancer damage in nasal delivery systems. II. Effect on in vivo absorption of insulin and histopathology of nasal membrane
41. Nasal toxicological investigations of Carbopol 971P formulation of apomorphine: Effects on ciliary beat frequency of human nasal primary cell culture and in vivo on rabbit nasal mucosa
42. Toxicological investigations of the effects carboxymethylcellulose on ciliary beat frequency of human nasal epithelial cells in primary suspension culture and in vivo on rabbit nasal mucosa
43. Morphologic examination of rabbit nasal mucosa after nasal administration of degradable starch microspheres
44. Toxicological aspects of the use of dextran microspheres and thermogelling ethyl (hydroxyethyl) cellulose (EHEC) in nasal drug delivery systems
45. Nasal absorption in the rat. II. A method to demonstrate the histological effects of nasal formulations
46. In vitro tolerability of human nasal mucosa: Histopathological and a scanning electron microscopic evaluation of nasal forms containing Sandostatin
47. Recovery of the nasal mucosa following laureth-9 induced damage
48. Effect of formulation variables on nasal epithelial cell integrity: Biochemical evaluations
49. Nasal membrane and intracellular protein and enzyme release by bile salts-fatty acid mixed micelles: Correlation with facilitated drug transport
50. Cyclodextrins as nasal absorption promoters of insulin: Mechanistic evaluations
51. Absorption of drugs from the nasal mucosa of rat
52. In situ perfusion is an unrealistic approach to assess the effects of absorption enhancers on nasal epithelium
53. Recovery of rat nasal mucosafrom the effects of aminopeptidase inhibitors
54. A rat nasal epithelial model for predicting upper respiratory tract toxicity: In vivo-in vitro correlation
55. Physical characteristics of collagen cell-support matrix affects in vitronasal drug delivery studies using primary cultures
56. Permeability and cytotoxicity of macromolecule from nasal formulation using EpiAirway tissue model
57. Effects of absorption enhancers on rat nasal epithelium in vivo: Release of marker compounds in the nasal cavity
58. Effect of bile salts on the nasal mucosa: Membrane potential measurement
59. Evaluation of enhancers to increase nasal absorption using Ussing chamber technique
60. Electrical properties of monolayers cultured from cells of human tracheal mucosa
61. Nasal drug delivery-evaluation of an in vitro model using porcine nasal mucosa
62. Recording of mucocilliary activity in vivo: Benefit of Fast Fourier Transform Analysis of the photoelectric signal
63. The influence of drugs on nasal ciliary movement
64. The nasal mucociliary clearance: Relevance to nasal drug delivery
65. Nasal mucociliary clearance as a factor in nasal drug delivery
66. Cryopreservation of human nasal ciliated epithelium
67. Effect of exogenous ATP on ciliary beat of human ciliated cells studied with differential interference microscope equipped with high-speed video
68. Cilio-genesis and coordinated ciliary beating in human nasal epithelial cells cultured in vitro
69. Safety assessment of selected cyclodextrins - Effect on ciliary activity using a human cell suspension culture model exhibiting in vitro cilio-genesis
70. Quantification of ciliary beat frequency by computerized microscope photometry - A preliminary study on suspension cultures of human nasal epithelia showing spontaneous ciliogenesis in vitro
71. Degeneration of human respiratory ciliary beat in monolayer cell cultures
72. Normal ciliary beat frequency after cilio-genesis in nasal epithelial cells cultured sequentially as monolayer and in suspension
73. Cell suspension cultures and adenoid epithelium: An assessment of the source of material for human ciliary function experiments in vitro
74. Influence of culture duration and cilio-genesis on the relationship between ciliary beat frequency and temperature in nasal epithelial cells
75. The effects of preservatives on the ciliary beat frequency of chicken tracheas
76. Lack of deleterious effects of corticosteroid sprays containing benzalkonium chloride on nasal ciliated epithelium
77. Chitosan as a nasal delivery system: The effect of solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers
78. Correlation between the sensitivity of the ciliary beat frequency of human adenoid tissue and chicken embryo tracheas for some drugs
79. Gastropods as an evaluation tool for screening the irritating potency of absorption enhancers and drugs
80. Application of a hybrid CFD-PBPK nasal dosimetry model in an inhalation risk assessment: An example with acrylic acid
81. DNA adduct formation in the human nasal mucosa as a biomarker of exposure to environmental mutagens and carcinogens
82. Characterization of the barrier properties of mucosal membranes
83. Thermal analysis of human stratum corneum
84. Calorimetric studies of the structural transitions of human erythrocyte membrane
85. Lipid thermotropic transitions in human stratum corneum
86. Use of thermal analysis to monitor the destruction of a phospholipid bilayer due to absorption enhancers
87. The reversibility of absorption promoter interaction with red blood cell membranes studied with differential scanning calorimetry
88. Alteration of superoxide dismutase activity in tracheal epithelial cells by asbestos and inhibition of cytotoxicity by antioxidants